Navigation Links
Uptake Medical Names J.C. MacRae as Chief Financial Officer
Date:11/16/2010

IRVINE, Calif., Nov. 16, 2010 /PRNewswire/ -- Uptake Medical Corp., the leading developer of medical technologies for interventional emphysema therapy, announced today that J.C. MacRae has joined the company as its vice president and chief financial officer.

MacRae comes to Uptake Medical with over 25 years experience in the medical specialty device and biopharmaceutical product industries. He most recently was a member of the senior management team at CoreValve, Inc., a catheter-based heart valve replacement company, recently acquired by Medtronic (MDT-NYSE), serving as chief financial officer and managing director of CoreValve Europe, BV. During his career to date, MacRae has held senior general and financial management positions with innovative medical product companies and has led three successful IPOs and numerous private financings, and has a broad range of experience that includes initial product launches worldwide, business development, product licensing, and mergers and acquisitions. MacRae graduated from University of California, Irvine and has a MBA from California State University, Fullerton.

Uptake Medical is developing the InterVapor System, a minimally invasive method of treating emphysematous lung tissue. InterVapor delivers thermal vapor to the diseased areas, reducing the lung volume, expanding breathing capacity and improving overall breathing mechanics. The InterVapor System employs a bronchoscopic vapor delivery catheter and vapor generator plus an individualized patient procedure program called IP3 that customizes the treatment to each patient's physiology and condition.

"We are excited to have J.C. join Uptake Medical with his extensive global financial and medical device industry experience. His direct experience and leadership in assisting medical technology companies achieve growth and profitability will be directly applicable to Uptake's near term plans including global expansion, manufacturing scale-up, international distribution and fundraising," noted King Nelson, president and chief executive officer of Uptake Medical.

About Uptake Medical

Uptake Medical™ Corp. is a developer of proprietary medical technologies for the treatment of lung diseases including emphysema. The company's core technology is InterVapor, a simple, minimally invasive, non-implantable interventional pulmonary therapy designed to measurably improve lung function and patient quality of life. More information and a list of participating clinical trial sites can be found at http://www.uptakemedical.com/.


'/>"/>
SOURCE Uptake Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
2. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
3. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
4. Argon Medical Devices Announces Exclusive License and Distribution Agreement for UltraStream™ Chronic Hemodialysis Catheter
5. Reportlinker Adds Global Medical Specialty Bags Industry
6. Dehaier Medical Announces Third Quarter 2010 Financial Results
7. Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results
8. Reprints Desk Bolsters Ultra-Rapid Document Delivery Service Through New Electronic Sourcing Agreement with the American Medical Association, Publisher of JAMA & Archives Journals
9. Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010
10. Dehaier Medical Announces Conference Call to Discuss Third Quarter 2010 Financial Results
11. MedClean Technologies Signs Contract with Gamma HealthCare Inc./Danner Medical Waste for MedClean 4500 Fixed-Based System, Services, and Consumables
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Company, Inc. (NYSE MKT: AXN) today announced that for the ... the Company achieved revenue of $8,195,839, a 27% improvement on ... 2015. --> --> The ... $2,068,635, or $.03 per share, up 265% from the net ... of fiscal year 2015. Gross margin for the three months ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
(Date:2/8/2016)... Calif. , Feb. 8, 2016  Sangamo ... in therapeutic genome editing, announced that the U.S. ... Company,s Investigational New Drug (IND) application for SB-318, ... life-long therapy for Mucopolysaccharidosis Type I (MPS I). ... enables Sangamo to initiate a Phase 1/2 clinical ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... ... A man who has struggled to quit smoking, a man who has struggled with hair ... solutions to his problems – and he did. Now Nabat, a serial entrepreneur featured as ... breakthrough inventions to the world and better people's lives. His own experience with nicotine addiction ...
(Date:2/8/2016)... ... 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving the ... has teamed up with Citizens Opposed to Domestic Abuse in support of its efforts ... all those victimized by the fear of violence in their own homes, donations may ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... Discover the Rocky Mountain region’s longest running and ... companies. Attendees also get to see the most incredible gardens and home improvement ... , at the Colorado Convention Center - 700 14th St. Denver CO, is an ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua ... on how healthcare companies can use newly released government data on populations and ... population and intervene and capture the value they create to succeed in new ...
Breaking Medicine News(10 mins):